Cargando…
Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy
BACKGROUND: Treatment remains uncertain for IgA nephropathy patients with mild to moderate proteinuria, for whom anti-hypertensive medication or the RAS blocker is not applicable due to low blood pressure. TRIAL DESIGN: A double blinded randomized trial. METHODS: The anti-proteinuric effect of tacro...
Autores principales: | Kim, Yong-Chul, Chin, Ho Jun, Koo, Ho Suk, Kim, Suhnggwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747236/ https://www.ncbi.nlm.nih.gov/pubmed/23977072 http://dx.doi.org/10.1371/journal.pone.0071545 |
Ejemplares similares
-
Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy
por: Hu, Tingyang, et al.
Publicado: (2018) -
Effect of Vitamin D and Tacrolimus Combination Therapy on IgA Nephropathy
por: Yuan, Dong, et al.
Publicado: (2017) -
Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study
por: Yu, Mi-yeon, et al.
Publicado: (2017) -
Correction: Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study
por: Yu, Mi-yeon, et al.
Publicado: (2018) -
Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
por: Zhao, Lijuan, et al.
Publicado: (2023)